How Common Is Signal-Intensity Increase in Optic Nerve Segments on 3D Double Inversion Recovery Sequences in Visually Asymptomatic Patients with Multiple Sclerosis?

References

1. 1.↵
   2. Wattjes MP,
   3. Rovira À,
   4. Miller D, et al

   ; MAGNIMS study group. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients. Nat Rev Neurol 2015;11:597–606 doi:10.1038/nrneurol.2015.157 pmid:26369511

   CrossRefPubMed
2. 2.↵
   2. Polman CH,
   3. Reingold SC,
   4. Edan G, et al

   . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria.” Ann Neurol 2005;58:840–46 doi:10.1002/ana.20703 pmid:16283615

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Swanton JK,
   3. Rovira A,
   4. Tintore M, et al

   . MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007;6:677–86 doi:10.1016/S1474-4422(07)70176-X pmid:17616439

   CrossRefPubMedWeb of Science
5. 5.↵
   2. McDonald WI,
   3. Compston A,
   4. Edan G, et al

   . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121–27 doi:10.1002/ana.1032 pmid:11456302

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Geurts JJ,
   3. Pouwels PJ,
   4. Uitdehaag BM, et al

   . Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254–60 doi:10.1148/radiol.2361040450 pmid:15987979

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Simon B,
   3. Schmidt S,
   4. Lukas C, et al

   . Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 2010;20:1675–83 doi:10.1007/s00330-009-1705-y pmid:20094887

   CrossRefPubMedWeb of Science
8. 8.↵
   2. Coebergh JA,
   3. Roosendaal SD,
   4. Polman CH, et al

   . Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging. Mult Scler 2010;16:1521–24 doi:10.1177/1352458510383302 pmid:20846999

   CrossRefPubMed
9. 9.↵
   2. Wattjes MP,
   3. Lutterbey GG,
   4. Gieseke J, et al

   . Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions. AJNR Am J Neuroradiol 2007;28:54–49 pmid:17213424

   Abstract/FREE Full Text
10. 10.↵
    2. Hodel J,
    3. Outteryck O,
    4. Bocher AL, et al

    . Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study. Eur Radiol 2014;24:3069–75 doi:10.1007/s00330-014-3342-3 pmid:25149294

    CrossRefPubMed
11. 11.↵
    2. Balcer LJ

    . Clinical practice: optic neuritis. N Engl J Med 2006;354:1273–80 doi:10.1056/NEJMcp053247 pmid:16554529

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Foroozan R,
    3. Buono LM,
    4. Savino PJ, et al

    . Acute demyelinating optic neuritis. Curr Opin Ophthalmol 2002;13:375–80 doi:10.1097/00055735-200212000-00006 pmid:12441840

    CrossRefPubMed
13. 13.↵
    2. Frohman EM,
    3. Frohman TC,
    4. Zee DS, et al

    . The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005;4:111–21 doi:10.1016/S1474-4422(05)00992-0 pmid:15664543

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Hickman SJ,
    3. Toosy AT,
    4. Miszkiel KA, et al

    . Visual recovery following acute optic neuritis: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 2004;251:996–1005 pmid:15316805

    PubMedWeb of Science
15. 15.↵
    2. Beck RW,
    3. Gal RL,
    4. Bhatti MT, et al

    ; Optic Neuritis Study Group. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 2004;137:77–83 doi:10.1016/S0002-9394(03)00862-6 pmid:14700647

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Brusa A,
    3. Jones SJ,
    4. Plant GT

    . Long-term remyelination after optic neuritis: a 2-year visual evoked potential and psychophysical serial study. Brain 2001;124:468–79 doi:10.1093/brain/124.3.468 pmid:11222447

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Cleary PA,
    3. Beck RW,
    4. Bourque LB, et al

    . Visual symptoms after optic neuritis: results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 1997;17:18–23; quiz 24–28 pmid:9093956

    PubMed
18. 18.↵
    2. Guy J,
    3. Mao J,
    4. Bidgood WD Jr., et al

    . Enhancement and demyelination of the intraorbital optic nerve: fat suppression magnetic resonance imaging. Ophthalmology 1992;99:713–19 doi:10.1016/S0161-6420(92)31892-5 pmid:1594216

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Guy J,
    3. Fitzsimmons J,
    4. Ellis EA, et al

    . Intraorbital optic nerve and experimental optic neuritis: correlation of fat suppression magnetic resonance imaging and electron microscopy. Ophthalmology 1992;99:720–25 doi:10.1016/S0161-6420(92)31905-0 pmid:1594217

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Hendrix L,
    3. Kneeland JB,
    4. Haugthon VM, et al

    . MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique. AJR Am J Roentegenol 1990;155:849–54 doi:10.2214/ajr.155.4.2119121 pmid:2114763

    CrossRefPubMed
21. 21.↵
    2. Johnson G,
    3. Miller DH,
    4. MacManus D, et al

    . STIR sequences in NMR imaging of the optic nerve. Neuroradiology 1987;29:238–45 doi:10.1007/BF00451760 pmid:3614619

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Sartoretti-Schefer S,
    3. Wichmann W,
    4. Valavanis A

    . Optic neuritis: characteristic magnetic resonance features and differential diagnosis. Int J Neuroradiol 1997;3:417–27
23. 23.↵
    2. Gala F

    . Magnetic resonance imaging of optic nerve. Indian J Radiol Imaging 2015;25:421–38 doi:10.4103/0971-3026.169462 pmid:26752822

    CrossRefPubMed
24. 24.↵
    2. Rizzo JF 3rd.,
    3. Andreoli CM,
    4. Rabinov JD

    . Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002;109:1679–84 doi:10.1016/S0161-6420(02)01148-X pmid:12208717

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Rocca MA,
    3. Hickman SJ,
    4. Bö L, et al

    . Imaging the optic nerve in multiple sclerosis. Mult Scler 2005;11:537–41 doi:10.1191/1352458505ms1213oa pmid:16193891

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Kupersmith MJ,
    3. Alban T,
    4. Zeiffer B, et al

    . Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 2002;125:812–22 doi:10.1093/brain/awf087 pmid:11912114

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Hickman SJ,
    3. Miszkiel KA,
    4. Plant GT, et al

    . The optic nerve sheath on MRI in acute optic neuritis. Neuroradiology 2005;47:51–55 doi:10.1007/s00234-004-1308-x pmid:15633052

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Youl BD,
    3. Turano G,
    4. Towell AD, et al

    . Optic neuritis: swelling and atrophy. Electroencephalogr Clin Neurophysiol Suppl 1996;46:173–79 pmid:9059791

    PubMed
29. 29.↵
    2. Youl BD,
    3. Turano G,
    4. Miller DH, et al

    . The pathophysiology of acute optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991;114:2437–50 doi:10.1093/brain/114.6.2437 pmid:1782525

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Miller DH,
    3. Newton MR,
    4. van der Poel JC, et al

    . Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988;38:175–79 doi:10.1212/WNL.38.2.175 pmid:3340276

    Abstract/FREE Full Text
31. 31.↵
    2. Jackson A,
    3. Sheppard S,
    4. Laitt RD, et al

    . Optic neuritis: MR imaging with combined fat- and water-suppression techniques. Radiology 1998;206:57–63 doi:10.1148/radiology.206.1.9423652 pmid:9423652

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Davies MB,
    3. Williams R,
    4. Haq N, et al

    . MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 1998;40:765–70 doi:10.1007/s002340050681 pmid:9877128

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Katdare A,
    3. Ursekar M

    . Systematic imaging review: multiple sclerosis. Ann Indian Acad Neurol 2015;18(suppl 1):S24–29 doi:10.4103/0972-2327.164821 pmid:26538845

    CrossRefPubMed
34. 34.↵
    2. Aiken AH,
    3. Mukherjee P,
    4. Green AJ, et al

    . MR imaging of optic neuropathy with extended echo-train acquisition fluid-attenuated inversion recovery. AJNR Am J Neuroradiol 2011;32:301–05 doi:10.3174/ajnr.A2391 pmid:21183615

    Abstract/FREE Full Text
35. 35.↵
    2. McKinney AM,
    3. Lohman BD,
    4. Sarikaya B, et al

    . Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident acute optic neuritis. Acta Radiol 2013;54:455–61 doi:10.1177/0284185113475444 pmid:23386735

    CrossRefPubMed
36. 36.↵
    2. Hadhoum N,
    3. Hodel J,
    4. Defoort-Dhellemmes S, et al

    . Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss. Mult Scler J 2016;22:649–58 doi:10.1177/1352458515598021 pmid:26227005

    CrossRefPubMed
37. 37.↵
    2. Tur C,
    3. Goodkin O,
    4. Altmann DR, et al

    . Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis. Brain 2016;139:816–28 doi:10.1093/brain/awv396 pmid:26912640

    CrossRefPubMed
38. 38.↵
    2. Ikuta F,
    3. Zimmerman HM

    . Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 1976;26:26–28 doi:10.1212/WNL.26.6_Part_2.26 pmid:944889

    FREE Full Text
39. 39.↵
    2. Toussaint D,
    3. Périer O,
    4. Verstappen A, et al

    . Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983;3:211–20 doi:10.3109/01658108308997307 pmid:6226722

    CrossRefPubMed
40. 40.↵
    2. Frohman EM,
    3. Costello F,
    4. Stüve O, et al

    . Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. Arch Neurol 2008;65:26–35 pmid:18195137

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Frohman EM,
    3. Fujimoto JG,
    4. Frohman TC, et al

    . Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008;4:664–75 pmid:19043423

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Hayreh SS

    2. Hayreh SS

    . Structure of the optic nerve. In: Hayreh SS, ed. Ischemic Optic Neuropathies. Heidelberg: Springer; 2011:7–34
43. 43.↵
    2. Lamirel C,
    3. Newman NJ,
    4. Biousse V

    . Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis. Rev Neurol (Paris) 2010;166:978–86 doi:10.1016/j.neurol.2010.03.024 pmid:20605617

    CrossRefPubMed
44. 44.↵
    2. Thrower BW

    . Clinically isolated syndromes: predicting and delaying multiple sclerosis. Neurology 2007;68:S12–25 doi:10.1212/01.wnl.0000277704.56189.85 pmid:17562845

    Abstract/FREE Full Text
45. 45.↵
    2. Frisén L,
    3. Hoyt WF

    . Insidious atrophy of retinal nerve fibers in multiple sclerosis: funduscopic identification in patients with and without visual complaints. Arch Ophthalmol 1974;92:91–97 doi:10.1001/archopht.1974.01010010097001 pmid:4847508

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Bambo MP,
    3. Garcia-Martin E,
    4. Perez-Olivan S, et al

    . Detecting optic atrophy in multiple sclerosis patients using new colorimetric analysis software: from idea to application. Semin Ophthalmol 2016;31:459–62 doi:10.3109/08820538.2014.96217162 pmid:25392265

    CrossRefPubMed
47. 47.↵
    2. Garcia-Martin E,
    3. Rodriguez-Mena D,
    4. Herrero R, et al

    . Neuro-ophthalmologic evaluation, quality of life and functional disability in patients with MS. Neurology 2013;81:76–83 doi:10.1212/WNL.0b013e318299ccd9 pmid:23709591

    Abstract/FREE Full Text
48. 48.↵
    2. Garcia-Martin E,
    3. Pueyo V,
    4. Ara JR, et al

    . Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients. Mult Scler 2011;17:830–37 doi:10.1177/1352458510397414 pmid:21300734

    CrossRefPubMed